Study title: Efficacy and tolerance evaluation of secnidazole suspension single dose (30 mg/kg/day) in the treatment of giardiasis in children - Dr Cimerman, Dr Katz, Dr Zingans - No date
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Parasitic Diseases [C03] | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report, Please see report | |||||
| Assessment: | |||||
| Active substance: SECNIDAZOLE | |||||
| ATC code: P01AB07 | |||||
| Document link: Secnidazole STUDY Cimerman.xls | |||||
| Document date: 2013-05-08 | |||||
| Study number: | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | - | - | |